Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Randomized, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of add-on Plasma-exchange as an Adjunctive Strategy Against Septic Shock

NCT03065751 is registered in ClinicalTrials.gov with Hannover Medical School as lead sponsor.

NCT NCT03065751
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03065751 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Randomized, Multicenter, Open-label, Controlled, Parallel-group Trial Investigating the Efficacy of add-on Plasma-exchange as an Adjunctive Strategy Against Septic Shock
Lead sponsor
Hannover Medical School
Phase
Not applicable
Overall status
Unknown status
Start date
January 31, 2016
Completion date
July 31, 2021
Enrollment
352 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

septic shock